AUROBINDO PHARMA

BSE: 524804 21 Oct 2025

Healthcare

₹ 1087.1

Aurobindo Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

AUROBINDO PHARMA

BSE: 524804 21 Oct 2025

Healthcare

₹ 1087.1

Aurobindo Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

Book Value

557.0

Dividend Yield

0.41%

Debt to Equity

0.25

Stock P/E

18.8

Market Cap

63,867 Cr

AUROBINDO PHARMA - Share Price & Details

Market Cap

₹63,867

High /Low

1,530 / 994.0

Stock P/E

18.8

Book Value

₹557.0

Dividend Yield

0.41

ROCE

14.2

ROE

₹11.1

Face Value

1.0

PEG Ratio

2.38

EVEBITDA

₹9.07

Debt

8,263

CMP / FCF

10,273

Debt to equity

₹0.25

NP Ann

3,484

High price all time

1,593

Piotroski score

₹6.0

Graham Number

852.0

No. Eq. Shares

58.6

Net CF

₹2,178

Net profit

3,390

Price to book value

1.96

Interest Coverage

₹12.2

Low price all time

10.1

Industry PE

33.0

Reserves

₹32,595

Free Cash Flow

₹1,408

Broker Recommendations

Date	Author	Type	Reco Price	Target Price	Potential	Source	PDF Link
06 Aug 2025	Prabhudas Lilladher	Buy	₹1,080	₹1,300	21.2%	moneycontrol	View
06 Aug 2025	ICICI Securities	Buy	₹1,072.8	₹1,300	21.5%	moneycontrol	View
05 Aug 2025	Motilal Oswal	Buy	₹1,080	₹1,300	21.2%	moneycontrol	View
27 May 2025	Prabhudas Lilladher	Buy	₹1,190.95	₹1,440	25.4%	moneycontrol	View
10 Feb 2025	KRChoksey	Buy	₹1,191.7	₹1,591	35.1%	moneycontrol	View
10 Feb 2025	Prabhudas Lilladher	Buy	₹1,176.8	₹1,510	31.5%	moneycontrol	View
08 Feb 2025	ICICI Securities	Buy	₹1,191.7	₹1,445	25.9%	moneycontrol	View
27 Nov 2024	Geojit Financial Services	Buy	₹1,223.95	₹1,540	23%	moneycontrol	View
13 Nov 2024	KRChoksey	Buy	₹1,249.4	₹1,591	27%	moneycontrol	View
12 Nov 2024	Prabhudas Lilladher	Buy	₹1,267.4	₹1,475	17.7%	moneycontrol	View
11 Nov 2024	Sharekhan	Buy	₹1,287.85	₹1,532	22.3%	moneycontrol	View
13 Aug 2024	Prabhudas Lilladher	Buy	₹1,505.1	₹1,525	21.4%	moneycontrol	View
12 Aug 2024	Motilal Oswal	Hold	₹1,460.4	₹1,500	19.4%	moneycontrol	View
29 May 2024	KRChoksey	Buy	₹1,218.3	₹1,295	2.4%	moneycontrol	View
28 May 2024	Prabhudas Lilladher	Buy	₹1,220.05	₹1,300	2.8%	moneycontrol	View
27 May 2024	Motilal Oswal	Hold	₹1,195.65	₹1,300	2.8%	moneycontrol	View
10 May 2024	Motilal Oswal	Hold	₹1,128.65	₹1,180	-6.6%	moneycontrol	View
20 Feb 2024	Sharekhan	Hold	₹1,052.7	₹1,133	-10.3%	moneycontrol	View
13 Feb 2024	Prabhudas Lilladher	Buy	₹1,026.4	₹1,120	-11.4%	moneycontrol	View

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.09	84.8
Triochem Products Ltd.,	2.21	-0.31	NA	-1.25	0
AUROBINDO PHARMA LTD.	29319.4	5591.3	28481.7	9.63	63,867	18.8
ABBOTT INDIA LTD.	18,111.90	3,658.60	17,383.50	172.17	63198	43.5
GLENMARK PHARMACEUTICALS LTD.	24642.63	3302.26	23949.28	11.7	55642	41.8

Peer Comparison Chart

About AUROBINDO PHARMA

Aurobindo Pharma Ltd., with Security Code 524804, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Order Book

Latest News

Aurobindo Pharma arm CuraTeQ Biologics incorporates new wholly owned subsidiary in Malta

(27 Sep 2025)

Hyderabad: Aurobindo Pharma has announced that CuraTeQ Biologics B.V., a wholly owned step-down subsidiary of the Company, has incorporated...

Is Aurobindo Pharma (NSE:AUROPHARMA) A Risky Investment?

(26 Sep 2025)

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to...

Pharma stocks led by Natco, Wockhardt fall up to 5% after US tariffs on generic, patented drugs

(26 Sep 2025)

Indian Pharma companies, from Sun Pharma Ltd. to Aurobindo Pharma Ltd., Gland Pharma Ltd., Lupin Ltd., Cipla Ltd. among others fell up to 5%...

Aurobindo Pharma arm incorporates new wholly owned subsidiary in Malaysia

(18 Sep 2025)

Aurobindo Pharma has announced that Helix Healthcare B.V., a wholly owned subsidiary of the Company, has incorporated a new wholly owned...

Stock Radar: Aurobindo Pharma stock showing signs of momentum after 30% fall from highs; what should inves

(17 Sep 2025)

Aurobindo Pharma rebounded after testing Rs 1000 in September 2025, reclaiming short-term moving averages. Experts suggest high-risk traders...

Aurobindo Pharma Expands into Malaysia with New Subsidiary

(17 Sep 2025)

An update from Aurobindo Pharma Ltd ( ($IN:AUROPHARMA) ) is now available. Aurobindo Pharma Ltd has announced the incorporation of a new...

Quarterly Table

Standalone Consolidated

Metrics	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Sales	3,547.4	2,390.8	2,668.8	2,692.0	2,894.0	2,460.1	2,824.6	2,916.6	2,732.0	2,848.2
Expenses	2,855.6	1,968.4	2,123.6	2,210.3	2,119.2	1,961.2	2,103.7	2,203.5	2,135.4	2,051.8
Operating Profit	691.8	422.4	545.2	481.7	774.8	498.9	720.9	713.2	596.6	796.3
OPM %	19.5%	17.67%	20.43%	17.89%	26.77%	20.28%	25.52%	24.45%	21.84%	27.96%
Other Income	288.2	94.9	67.1	331.1	123.0	65.3	122.7	54.3	114.0	83.8
Interest	49.0	31.6	36.7	61.3	53.1	51.1	51.6	66.2	61.1	60.0
Depreciation	115.0	59.6	65.8	64.4	64.8	66.9	68.2	68.3	93.9	70.0
Profit before tax	816.0	426.0	509.8	687.2	779.9	446.2	723.8	632.9	555.6	750.1
Tax %	-21%	-25.4%	-25.5%	-9.2%	-25.8%	-26.3%	-25.7%	-25.4%	-26.5%	25.5%
Net Profit	644.8	336.0	415.7	623.8	578.7	329.0	537.5	472.1	408.2	559.1
EPS in Rs	11	5.74	7.1	10.65	9.88	5.62	9.21	8.13	0	9.63

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	6,407.1	6,473.0	6,850.5	7,219.4	7,351.8	7,580.2	7,567.0	7,796.1	7,978.5	8,382.1
Expenses	5,453.3	5,476.6	5,702.0	5,846.0	5,753.1	5,920.0	5,948.8	6,229.9	6,400.5	6,622.3
Operating Profit	953.8	996.3	1,148.6	1,373.4	1,598.7	1,660.2	1,618.2	1,566.1	1,578.0	1,759.8
OPM %	14.89%	15.39%	16.77%	19.02%	21.75%	21.9%	21.38%	20.09%	19.78%	20.99%
Other Income	92.7	134.9	46.6	187.0	162.5	13.5	220.9	136.0	157.3	134.8
Interest	45.0	55.6	56.6	68.2	75.6	89.4	111.0	112.7	118.5	115.0
Depreciation	321.4	345.6	326.6	417.5	423.3	354.3	404.2	382.3	418.5	444.4
Profit before tax	680.1	730.1	881.8	1,074.7	1,262.4	1,352.0	1,323.9	1,207.2	1,198.3	1,335.1
Tax %	-27.8%	-30.5%	-29.7%	-30.1%	-25.5%	-26%	-30.6%	-32.3%	-29.6%	-31.6%
Net Profit	491.0	505.9	569.7	751.9	940.0	907.4	918.2	817.0	845.6	902.8
EPS in Rs	8.38	8.64	9.74	12.83	16.04	15.51	15.69	14	14.56	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	4%
5 Years:	-3%
3 Years:	-12%
TTM:	9%

Compounded Profit Growth
10 Years:	5%
5 Years:	5%
3 Years:	-14%
TTM:	0%

Stock Price CAGR
10 Years:	6%
5 Years:	10%
3 Years:	30%
1 Year:	-3%

Compounded Sales Growth
10 Years:	14%
5 Years:	8%
3 Years:	5%
TTM:	11%

Compounded Profit Growth
10 Years:	11%
5 Years:	6%
3 Years:	-1%
TTM:	27%

Stock Price CAGR
10 Years:	6%
5 Years:	10%
3 Years:	30%
1 Year:	-3%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Stock Mutual Funds Data

Order Book

News Date ▲▼	Headline ▲▼	Issuer Entity ▲▼	Issuer Type ▲▼	Order Size ▲▼	Time Period ▲▼
Loading company updates…

Loading technicals…

Moving Averages

Latest Close: — • Records Used: — • Last Trading Date: —

Simple Moving Averages (SMA)

Period	SMA Value	Status

Exponential Moving Averages (EMA)

Period	EMA Value	Status

Oscillators

Key Oscillators

latest calculation

Indicator	Value

AUROBINDO PHARMA

AUROBINDO PHARMA

AUROBINDO PHARMA - Share Price & Details

Broker Recommendations

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About AUROBINDO PHARMA

Order Book

Latest News

Aurobindo Pharma arm CuraTeQ Biologics incorporates new wholly owned subsidiary in Malta

Is Aurobindo Pharma (NSE:AUROPHARMA) A Risky Investment?

Pharma stocks led by Natco, Wockhardt fall up to 5% after US tariffs on generic, patented drugs

Aurobindo Pharma arm incorporates new wholly owned subsidiary in Malaysia

Stock Radar: Aurobindo Pharma stock showing signs of momentum after 30% fall from highs; what should inves

Aurobindo Pharma Expands into Malaysia with New Subsidiary

Aurobindo Pharma Ltd gains for third straight session

Here's why Aurobindo Pharma shares jumped 6% on Thursday

Closing Bell: Waaree Energies, Aurobindo Pharma among top gainers as Nifty closes at 25,005; Sensex gains 123 points

STOCKS IN NEWS: ACME Solar Holdings Ltd, Zydus Lifesciences, Aurobindo Pharma, Adani Power, Asian Energy Services, Ujjivan Small Finance Bank, Dee Development Engineers Ltd, Samvardhana Motherson International and others

Aurobindo Pharma Shares Slump 1% on 8 USFDA Observations

Stocks in news: Hyundai India, Vedanta, Adani Power, Tata Motors, Aurobindo Pharma

USFDA inspection: Aurobindo Pharma receives 8 observations for Unit-XII

US FDA wraps up Aurobindo Pharma’s Bachupally plant inspection with 8 observations

Aurobindo Pharma's: unit gets FDA Form 483 with 8 observations

We Discuss Whether Aurobindo Pharma Limited's (NSE:AUROPHARMA) CEO Is Due For A Pay Rise

Stocks to Watch, September 1: Aurobindo Pharma, RIL, auto stocks, Ather Energy, NCC, BEML, Adani Power, Torrent Power

Aurobindo Pharma arm Telangana facility gets 5 USFDA observations

Aurobindo Pharma’s Apitoria Unit Completes US FDA Inspection with Procedural Observations

Estimating The Fair Value Of Aurobindo Pharma Limited (NSE:AUROPHARMA)

Aurobindo Pharma arm secures UK regulator’s approval for breast cancer treatment drug

Aurobindo Pharma Shares Slump 2% on Securing Approval in the UK

Aurobindo Pharma's subsidiary CuraTeQ Biologics Secures MHRA Approval for Trastuzumab Biosimilar Dazublys ...

Aurobindo Pharma Exclusive: CFO says Zentiva fits into strategic plans, but talks in 'early stage'

Aurobindo Pharma shares tumble almost 5% on reports of Zentiva acquisition bid; company issues clarification

Aurobindo Pharma acquisition news: Drugmaker says 'no binding agreement' yet

Aurobindo Pharma Ltd soars 1.82%

Aurobindo Pharma AGM scheduled

Aurobindo Pharma Q1 FY26 PAT slips 10% YoY to Rs. 824 Cr

Aurobindo Pharma Q1 Results Review: Motilal Oswal Maintains Buy — Check Target Price

Stock Picks Today: Escorts Kubota, Marico, IndusInd Bank, Aurobindo Pharma On Brokerages Radar

Aurobindo Pharma Q1 Updates: Net Profit slips 10.20% y-o-y

Stocks to Watch today, Aug 5: IndusInd Bank, DLF, Aurobindo Pharma, Bosch

Board of Aurobindo Pharma recommends interim dividend

Aurobindo Pharma net profit drops 10 percent to Rs 824 crore in Q1

Aurobindo Pharma Q1 results FY26: Check profit, revenue and other earnings details

Aurobindo Pharma Declares Dividend Of Rs 4 — Check Record Date, Details

Marico, Aurobindo Pharma, Kansai Nerolac, DLF, Escorts Kubota Q1 Results Today — Earnings Estimates

Aurobindo Pharma Q1 Results: Misses estimates, revenue up 4%; declares dividend

Hyderabad-based Aurobindo Pharma’s Q1 net profit falls 10 per cent to Rs 824 crore

Q1 Results Highlights: Aurobindo Pharma misses Street estimates, Bosch revenue up 11%

Aurobindo Pharma Q1 Results: Profit Falls 10%, Misses Estimates

Aurobindo Pharma Limited (AUROPHARMA) vs yyy - Free Daily Trading Room Entry

Aurobindo Pharma Limited (524804) Announces Strategic Shift - Build wealth steadily with proven investment techniques

Aurobindo Pharma Acquires Lannett for Rs 2,185 Cr to Boost U.S. Presence, ADHD Line

Aurobindo Pharma Unit to Buy Lannett Company LLC for $250 Million, Shares Trading Flat

Aurobindo Pharma Share Price Steady As It Announces $250 Million Lannett Acquisition

Aurobindo Pharma to Acquire U.S.-based Lannett for $250 Million

Aurobindo Pharma's (NSE:AUROPHARMA) 28% CAGR outpaced the company's earnings growth over the same three-year period

Aurobindo Pharma stock in focus: Buy on dips, says Anil Singhvi despite tariff overhang

Aurobindo Pharma arm to acquire 100% stake in Lannett Company LLC for $250 million

Gland Pharma Ltd up for third consecutive session

aurobindo pharma acquires lannett company for usd 250mn

Aurobindo Pharma Limited (524804) Announces Strategic Shift - Free Stock Selection

Would You Accumulate or Wait on Aurobindo Pharma Limited (AUROPHARMA) - Exceptional profit velocity

Aurobindo Pharma Limited (AUROPHARMA) Announces Strategic Shift - Superior portfolio returns

Aurobindo Pharma Limited (AUROPHARMA) vs yyy - Accelerated investment success

Aurobindo Pharma Limited (AUROPHARMA) Signs Major Deal - Unmatched market gains

Aurobindo Pharma Limited (AUROPHARMA) Signs Major Deal - Exceptional gains

Aurobindo Pharma to hold board meeting

Aurobindo Pharma Limited (524804) Stock Rallies - Outstanding capital returns

Would You Accumulate or Wait on Aurobindo Pharma Limited (AUROPHARMA) - Skyrocketing profit margins

Aurobindo Pharma Limited (524804) Announces Strategic Shift - Market-beating performance

Can Aurobindo Pharma Limited (AUROPHARMA) Maintain Its Valuation - Phenomenal returns

Aurobindo Pharma Limited (AUROPHARMA) vs yyy - Unprecedented profits

Aurobindo Pharma Limited (524804) Announces Strategic Shift - Breakout stock performance

Aurobindo Pharma Limited (AUROPHARMA) vs yyy - High-octane financial growth

Aurobindo Pharma Limited (AUROPHARMA) Announces Strategic Shift - High-performance investment picks

Stock market update: Nifty Pharma index falls 0.06% in an upbeat market